Chimeric antigen receptor T cell therapies for thoracic cancers-challenges and opportunities

Jack D Chan; Aaron J Harrison; Phillip K Darcy; Michael H Kershaw; Clare Y Slaney

Journal article

Chimeric antigen receptor T cell therapies for thoracic cancers-challenges and opportunities

Jack D Chan, Aaron J Harrison, Phillip K Darcy, Michael H Kershaw, Clare Y Slaney

JOURNAL OF THORACIC DISEASE | AME PUBL CO | Published : 2020

DOI: 10.21037/jtd.2020.03.34

University of Melbourne Researchers

Phillip Darcy Author The Sir Peter Maccallum Department of Oncology

Clare Slaney Author The Sir Peter Maccallum Department of Oncology

Michael Kershaw Author The Sir Peter Maccallum Department of Oncology

Related Projects (6)

CAR T CELLS AND "A GOOD BEATING" FOR CANCER THERAPY

ADOPTIVE CELL TRANSFER INCORPORATING VACCINATION (ACTIV) THERAPY FOR CANCER

We have made a breakthrough in a new treatment for cancer that can destroy large tumours in mice. The treatment involves a transfusion of wh..

IMMUNOBIOLOGY AND IMMUNOTHERAPY OF CANCER

For 60 years, we have had only 3 effective cancer treatments: surgery, radiation and chemotherapy, often used in combination.The last 5 year..

USING LESSONS FROM TOXIC SHOCK SYNDROME TO ENHANCE BREAST CANCER IMMUNOTHERAPY

CAR T CELLS AND A GOOD “BEATING” FOR BREAST CANCERS

TARGETING BREAST CANCER USING ADOPTIVE CELL TRANSFER INCORPORATING VACCINATION

Grants

Awarded by National Health and Medical Research Council (NHMRC) of Australia

Awarded by National Breast Cancer Foundation (NBCF) of Australia

Awarded by Susan G. Komen Breast Cancer Foundation

Funding Acknowledgements

This work was supported by grants from the Peter MacCallum Cancer Centre Foundation, the National Health and Medical Research Council (NHMRC) of Australia (1176935, 1103352 and 1132373), the National Breast Cancer Foundation (NBCF) of Australia (IIRS-18064 and IIRS-20-073) and Susan G. Komen Breast Cancer Foundation (16376637). JDC was supported by a Research Training Program (RTP) and Rosie Lew scholarships. PKD and MHK were supported by NHMRC Senior Research Fellowships. CYS was supported by a Postdoctoral Fellowship from the NBCF.